Cure My Disease

Don't miss your cure!

 Log in / Sign up

New PET tracer could spare prostate cancer patients from repeated biopsies

NCT ID NCT06474806

Recruiting now Diagnosis Sponsor: Curasight Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a radioactive tracer called 64Cu-DOTA-AE105 can accurately show the aggressiveness of prostate cancer on a PET scan. About 168 men with low- to intermediate-risk prostate cancer will receive the tracer and undergo imaging. The goal is to see if this scan can replace or reduce the need for repeated tissue biopsies during active surveillance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
64Cu-DOTA-AE105 (a radioactive tracer injected into the vein for PET imaging)
What this could lead to
If successful, this imaging agent could help doctors determine prostate cancer aggressiveness without repeated biopsies, improving monitoring for low-risk patients.
What could go wrong
This is an early-phase trial with only 168 participants, so results may not apply to all patients. The imaging accuracy may not be high enough to replace biopsies yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Aalborg University Hospital

    RECRUITING

    Aalborg, Denmark

  • Herlev & Gentofte Hospital

    RECRUITING

    Herlev, Copenhagen, Denmark

  • Klinikum rechts der Isar

    RECRUITING

    Munich, Germany

  • Martini-klinik am UKE

    RECRUITING

    Hamburg, Germany

  • Sahlgrenska University Hospital

    RECRUITING

    Gothenburg, 41345, Sweden

  • Skåne University Hospital

    RECRUITING

    Skåne, 20502, Sweden

  • Universitätsklinikum, Düsseldorf

    RECRUITING

    Düsseldorf, Germany

  • Vejle Hospital

    RECRUITING

    Vejle, Denmark, 7100, Denmark

  • Zeisigwaldkliniken Bethanien Chemnitz

    RECRUITING

    Chemnitz, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.